MARKET WIRECNBC • 2h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Why CBT Stock advanced +0.11% Today — RQD Quant Desk Flash
$73.85 +0.11% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $74.04
Cabot Corporation (CBT) earns a Roarable Rating of B+ (Buy) with 77/100 RQD Confidence. High-quality cash engine (25% profit margin, 22% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.
ROARABLE B+ • BUY
Cap $3.81B
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $74.04 (+0.26%)🧬 Cannibal Buyback (-2.92% YoY Shares)⚙️ Cash Engine: 16/20 (B+) • 10.5% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 77/100 (B+) historically ranked in the Top 10% of excess returns over the next 90 days (+7.8% avg 90D alpha vs SPY • 70.3% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERBUY • B+
3-of-3 JEV AI Jury Bullish
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw B · Rk B+
Each axis scored 0–20
12M PRICE TARGET CONE+8.5% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CBT)Realized 20D OHLCV Swing Band: ±4.5%
Deterministic 5-Pillar Attribution (77/100 Composite)
🔍 WHY CBT SCORES 77/100 (B+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Insider Conviction & Share Dilution+18/20 pts (23% of score)
SEC Form 4 / 13F Thermometer: 86% Net Buy • Cannibal Buyback (-2.92% YoY Shares)
▲ #2 Bullish Driver: Macro Regime Fit+17/20 pts (22% of score)
FRED Regime × Technicals: 43% of 52W Range • RSI-14 at 43.4 (NEUTRAL RANGE)
▼ #1 Drag / Risk Factor: Whale & Options Positioning11/20 pts (-9 pt drag)
Put hedging (50% put share) caps near-term gamma upside (-9 pts vs max)
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade A$74.91-0.8% Next Q
85
Q2 (-2Q)Grade A$74.29-0.7% Next Q
82
Q3 (-1Q)Grade A-$73.79+0.1% Next Q
80
CurrentGrade B+$73.85+7.8% Hist 90D α
77
Trajectory: A (85) → B+ (77)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER
⚔️ Adversarial Opposing Case: Why the CBT Bull Thesis Could Fail
Even with a 77/100 (B+) score, CBT faces multiple-compression risk if 11.5x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
⚠️ Forensic Kill-Switch #1
Broader market pullbacks can still drag down strong stocks in the short run.
⚠️ Forensic Kill-Switch #2
Dilution & Margin Drag: Cannibal Buyback (-2.92% YoY Shares) — any gross margin slip below 22.8% triggers an automatic RQD downgrade.
⚠️ Forensic Kill-Switch #3
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($77.95) or 200D SMA ($79.54) invalidates the momentum regime and cuts Target Base ($80.16) toward Bear Floor ($60.56).
🎲 LIVE PREDICTION MARKET ODDS TIED TO $CBT• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “CBT Beats Next Quarter EPS Consensus (Dec 29, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why CBT Stock advanced +0.11% Today — RQD Quant Desk Flash
Cabot Corporation (CBT) advanced +0.11% to $73.85, trading at 43% of its 52-week range ($58.33 – $94.53). High-quality cash engine (25% profit margin, 22% return on capital) with steady institutional support.
- ▸Technical Tape: Trading at 43% of its 52-week range ($58.33 – $94.53) with RSI-14 at 43.4 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±4.5% around $73.85 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable B+ (Buy) backed by 25.3% gross margin and $391.0M annual free cash flow.
Live CBT Headlines & Catalysts
MARKET WIRECNBC • 3h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 4h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 5h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 6h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 7h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 7h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
MARKET WIREReuters • 7h ago
German ministers pledge tough action after rioters damage stores in Frankfurt - ReutersGerman ministers pledge tough action after rioters damage stores in Frankfurt Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk
Scheduled RQD Strong Buys & Whale Accumulation Briefing (CBT Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
CBT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -4.04%📐 HORIZONTAL RANGE
2026-10-30O $73.91H $74.63L $73.50C $73.85VOL 664.0K
RES: $98.90SUP: $71.71SMA50: $77.95SMA200: $79.54
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
CBT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
1.6%/yr Implied 5Y Growth
vs. -7.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on CBT today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for CBT. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for CBT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CBT)
Materials Rank #4 of 270
⚔️ AVNT vs CBT Full Matrix →
1. Head-to-Head Materials Peer Comparison (CBT vs. AVNT, VVV, PRM, MEOH)
Industry: Major Chemicals (67 Tracked Issuers)Across 270 tracked Materials securities in the Roarable RQD universe, Cabot Corporation (CBT) ranks #4 by composite RQD confidence (77/100, grade B+) and #86 by equity capitalization ($3.81B). Within this direct 5-issuer industry benchmark cohort, CBT leads on earnings valuation at 11.5x trailing P/E, while CBT leads on capital efficiency and profitability with 22.3% ROIC and 25.3% gross margin. CBT currently leads its immediate peer cohort in composite quantitative strength at 77/100 (B+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| CBT
ACTIVE
Cabot Corporation | B+ | 77/100 | 11.5x | 25.3% | 22.3% | +0.11% | $3.81B | Benchmark Subject |
| AVNT Avient Corporation | B- | 70/100 | 48.0x | 31.2% | 3.7% | +1.64% | $3.93B | /avnt-vs-cbt → |
| VVV Valvoline Inc. | D | 45/100 | 19.6x | 38.5% | 16.5% | +1.92% | $4.13B | /vvv-vs-cbt → |
| PRM Perimeter Solutions SA | D | 51/100 | — | 57.5% | -10.8% | -0.14% | $4.67B | /prm-vs-cbt → |
| MEOH Methanex Corporation | D | 51/100 | — | — | — | -1.24% | $4.86B | /meoh-vs-cbt → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-09-30 • CIK 0000016040In its most recent audited fiscal period (FY2025, filed 2025-09-30), Cabot Corporation (CBT) reported GAAP revenue of $3.71B (-7.0% vs. FY2024 revenue of $3.99B , and -5.5% cumulative change since FY2023) , GAAP net income of $331.0M, operating cash flow of $665.0M, and free cash flow of $391.0M (-13.3% YoY). On the balance sheet, CBT closed FY2025 with $3.76B in total assets against $854.0M in total debt (Altman Z-Score: N/A, Piotroski F-Score: 7/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-09-30 | $3.71B | $331.0M | $665.0M | $391.0M | $3.76B | $854.0M |
| FY2024 (FY) | 2024-09-30 | $3.99B | $380.0M | $692.0M | $451.0M | $3.64B | $1.09B |
| FY2023 (FY) | 2023-09-30 | $3.93B | $445.0M | $595.0M | $595.0M | — | — |
3. CBT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs CBT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Cabot Corporation (NYSE: CBT) is rated B+ (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 77/100 at a spot price of $73.85 (+0.11% 1D, market cap $3.81B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 15/20, FRED Macro Regime Fit 17/20, and SEC Balance-Sheet Forensics 18/20. Across 270 tracked Materials issuers, CBT ranks #4 in composite RQD confidence.
How does CBT compare to AVNT and VVV in the Materials sector?
Within the Materials sector (Major Chemicals), CBT carries a Roarable B+ (77/100 RQD), trailing P/E of 11.5x, gross margin of 25.3%, and ROIC of 22.3%. By comparison, AVNT (Avient Corporation) holds a B- grade (70/100 RQD, P/E 48.0x, ROIC 3.7%, cap $3.93B) and VVV (Valvoline Inc.) posts a D grade (45/100 RQD, P/E 19.6x, ROIC 16.5%, cap $4.13B). Among the 5-stock peer group, CBT leads on earnings multiple (11.5x) while CBT leads on capital efficiency (22.3% ROIC).
What are the biggest fundamental strengths and SEC risk factors for CBT?
Per CBT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-09-30, CIK 0000016040), Cabot Corporation generated $3.71B in revenue (-7.0% YoY), $331.0M in net income, and $391.0M in free cash flow against $3.76B in total assets and $854.0M in total debt. Key quantitative strengths: Strong cash generator (25% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is CBT trading relative to its 50-day, 200-day, and 52-week technical levels?
CBT last traded at $73.85 (+0.11% on volume of 392,283 shares), positioning the stock -5.26% below its 50-day simple moving average ($77.95) and -7.15% below its 200-day simple moving average ($79.54). Across its 52-week range of $58.33 to $94.53, CBT sits at the 42.9% percentile with a 14-day RSI of 43.4 (NEUTRAL RANGE) and an implied next-earnings move of ±4.5% ($70.53 to $77.17).
CBT Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is CBT stock moving today?
Why CBT Stock advanced +0.11% Today — RQD Quant Desk Flash. High-quality cash engine (25% profit margin, 22% return on capital) with steady institutional support.